Navigation Links
Actavis and Warner Chilcott Announce Effectiveness of Registration Statement on Form S-4
Date:7/31/2013

must not be, released, published, mailed or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction. Persons receiving such documents (including, without limitation, nominees, trustees and custodians) should observe these restrictions. Failure to do so may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies involved in the proposed Acquisition disclaim any responsibility or liability for the violations of any such restrictions by any person.

Any response in relation to the Acquisition should be made only on the basis of the information contained in the Scheme Circular or any document by which the Acquisition and the Scheme are made. Actavis Shareholders and Warner Chilcott Shareholders are advised to read carefully the formal documentation in relation to the proposed transaction once the Scheme Circular has been dispatched.CONTACTS: Actavis:Investors:Lisa DeFrancesco (862) 261-7152Media:Charlie Mayr(862) 261-8030Warner Chilcott:Rochelle FuhrmannSVP, Finance(973) 442-3281Kevin CrisseyDirector, Investor Relations(973) 907-7084(Logo:  http://photos.prnewswire.com/prnh/20130124/NY47381LOGO)


'/>"/>
SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
10. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
11. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Respiratory Motion and IMI Co announced today ... services providers in Japan , will ... respiratory depression monitor, the ExSpiron™. As part of this ... to connect the clinical community in promoting patient safety. ... innovative medical devices and new technology to the Japanese ...
(Date:11/18/2014)... and SAN DIEGO , ... HPPI), a clinical stage biopharmaceutical company that discovers, ... patients with cancer, announced today that it filed ... U.S. Food and Drug Administration (FDA) on Friday, ... covers HPPI,s proposed clinical development of a patented ...
(Date:11/18/2014)... Nov. 18, 2014 BioLink 2015, the ... Transfer Summit, co-organized by CCCMHPIE ( China Chamber ... Medicines & Health Products), UBM Live and Beijing ... 23rd, 2015 at Beijing Yizhuang Biomedical Park. ... This event will gather 200+ decision ...
Breaking Medicine Technology:Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4HedgePath Pharmaceuticals Files IND Application 2HedgePath Pharmaceuticals Files IND Application 3HedgePath Pharmaceuticals Files IND Application 4BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 3
... , , , , ... today issued the following letter to all shareholders. , , ... this letter is to update you on activities at the company. ... these letters as a means to provide insight to you on topical ...
... , , THOUSAND ... today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 ... anemia and type-2 diabetes (the T rial to R ... herapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to ...
Cached Medicine Technology:Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 2Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 3Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 4Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 2Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 3Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 6Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 7Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 8
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- The cost of ... percent in recent years, climbing to more than $322 ... increases in cost were seen with prediabetes care, which ... jumped 82 percent, the researchers added. In 2012, ... totaled more than $1,000 for every American. That total ...
(Date:11/21/2014)... 2014 (HealthDay News) -- Scientists say they,ve mapped the genome ... a British man,s brain, in hopes it might help others ... in the journal Genome Biology , the tapeworm was ... Chinese ethnicity. "This infection is so rare worldwide and ... diagnosed ... until the worm was pulled out from the ...
(Date:11/21/2014)... IN (PRWEB) November 21, 2014 MLF ... dogs and cats . Liv-Pro® Probiotics for Pets helps ... balance back to a pet's intestinal flora after it ... treatment. , Liv-Pro Probiotics for Pets is a ... additives. It contains seven live active bacteria strains that ...
(Date:11/21/2014)... 2014 Saint Luke’s Mid America ... Guidelines®–Heart Failure Gold-Plus Quality Achievement Award for implementing ... Heart Association/American College of Cardiology Foundation in their ... Get With The Guidelines–Heart Failure is a quality ... most up-to-date, research-based guidelines with the goal of ...
(Date:11/21/2014)... Orange County, CA (PRWEB) November 21, 2014 ... be featured in an upcoming episode of Innovations with ... 2015. Dates and show times TBA. , Big Bud ... with information for growing, harvesting, and utilization of medical ... look at Big Bud Farms’ wide variety of products ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2
... be harmful, researchers warn , WEDNESDAY, Nov. 11 (HealthDay News) ... floors comes from outdoors and can pose a health threat, ... model that can track the distribution of outdoor soil and ... percent of household dust originates from tracked-in soil and airborne ...
... Afghanistan and Iraq are placing unprecedented pressures on today,s soldiers, ... The tragedy last week at Fort Hood, Texas, where an ... 13 people and wounding 29 others in a shooting rampage, ... in Afghanistan and Iraq, but also on another casualty of ...
... ... at this year,s Molecular Medicine Tri-Conference, is the inspiration for a new film which ... ... -- Cambridge Healthtech Institute,s (CHI) flagship event, the Molecular Medicine Tri-Conference (February 3-5, 2010) ...
... are in U.S. dollars , QUEBEC CITY, Nov. 11 /PRNewswire-FirstCall/ ... a global biopharmaceutical company focused on endocrinology and oncology, today ... three-month and nine-month periods ended September 30, 2009. , , ... - July 7, 2009. Publication in Proceedings of the National ...
... affiliated Life and Disability Companies are pleased to announce Newborn ... new mothers adjust to their newborn baby and return to ... to all new and in-force short term disability plans offered ... access to Newborn and Parenting Resources once their baby arrives ...
... LONDON, November 11 Extensive research conducted by ... of,Sheffield on the Simbionix PROcedure Rehearsal Studio(TM), was awarded ... congress in Lisbon, Portugal. , ... is,the world,s first patient specific system to enable clinicians ...
Cached Medicine News:Health News:Modern Wars, Modern Ills 2Health News:Modern Wars, Modern Ills 3Health News:Modern Wars, Modern Ills 4Health News:CHI's Molecular Medicine Tri-Conference Keynote John Crowley Inspires Feature Film Starring Harrison Ford 2Health News:CHI's Molecular Medicine Tri-Conference Keynote John Crowley Inspires Feature Film Starring Harrison Ford 3Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 2Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 3Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 4Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 5Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 6Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 7Health News:WellPoint's Affiliated Life and Disability Companies Offer Newborn and Parenting Resources to Ease New Mothers' Transition Back to Work After Maternity Leave 2Health News:Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009 2Health News:Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009 3
... is a stand-alone real-time monitoring, recording ... user defined set up, continuous monitoring ... and humidity. It offers non-restrictive sensor ... blood banks, laboratories, refrigerators, freezers, incubators ...
The ThermaViewer™ is constructed and engineered for use in laboratories, hospitals, and commercial kitchens to monitor and document freezer and refrigerator temperatures where inventory is store...
... tests confirmed Sterillium Rub's extremely effective and ... (Time Kill study and Tentative Final Monograph ... one European test - with the result ... efficacy specifications. Sterillium Rub with its high ...
... requiring no water for use, ... hygiene to physically clean hands ... either not an option or ... you to return to patient ...
Medicine Products: